Search

everythinglearnresearchcommunity

for

Search:↓

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

Isotretinoin shows promise as a treatment for Chagas disease by effectively inhibiting key transporters in the parasite.

A patient with complete hair loss regrew all her hair using tofacitinib.

Boron/nitrogen-doped carbon nano-onions improve targeted breast cancer treatment by enhancing drug delivery and reducing side effects.

Immunoadsorption successfully treated a man's resistant polymyositis.

Tofacitinib can cause unusual hair growth, requiring careful monitoring and possible laser hair removal.

Tofacitinib may help treat hair loss in children with alopecia areata.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

Troglitazone increases subcutaneous fat in lipodystrophy patients.

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.

Ixekizumab has known and some unexpected side effects.

New markers can detect tumors, aid drug delivery, and treat cancer effectively and safely.

Nano-Pulse Stimulation™ Therapy is more effective and less damaging than cryoablation for treating melanoma tumors in mice.

Chemotherapy may help with survival in children with medulloblastoma, but more research is needed.

Combining DEB-BACE with chemotherapy is more effective and has fewer side effects than chemotherapy alone for treating unresectable lung squamous cell carcinoma.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

Ablative fractional laser treatment nearly matches the gene reduction effects of topical vismodegib in skin cancer.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

Tofacitinib effectively regrows hair in alopecia areata but may need continuous use.

A patient developed nerve problems as a side effect of a hair loss treatment called tofacitinib.

Nemolizumab improved both severe atopic dermatitis and alopecia areata in one patient.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

2% Minoxidil does not prevent hair loss during chemotherapy.

Vismodegib is effective for basal cell carcinoma but has severe side effects.

Tofacitinib might be used to treat hair loss.

Low-dose oral minoxidil combined with topical minoxidil improves hair growth in breast cancer patients with therapy-induced hair loss.

New micelle solutions greatly improve skin delivery of certain antifungal drugs.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.